Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,034 INR | -0.47% | -2.41% | +21.14% |
Sales 2024 * | 121B 1.46B | Sales 2025 * | 140B 1.69B | Capitalization | 292B 3.51B |
---|---|---|---|---|---|
Net income 2024 * | 33.36B 401M | Net income 2025 * | 11.13B 134M | EV / Sales 2024 * | 2.57 x |
Net Debt 2024 * | 19.84B 238M | Net cash position 2025 * | 3.08B 36.98M | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
40.8
x | P/E ratio 2025 * |
24
x | Employees | 15,556 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.27% | Free-Float | 49.03% |
Latest transcript on Glenmark Pharmaceuticals Limited
1 day | -0.47% | ||
1 week | -2.41% | ||
Current month | +7.93% | ||
1 month | +8.78% | ||
3 months | +20.55% | ||
6 months | +36.14% | ||
Current year | +21.14% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Chief Executive Officer | 54 | 98-10-11 | |
Ulhas Dhuppad
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-13 | |
Cherylann Pinto
BRD | Director/Board Member | 56 | 99-10-05 |
Chief Executive Officer | 54 | 98-10-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | +0.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1,034 | -0.47% | 1,223,564 |
24-04-22 | 1,039 | +1.26% | 260,452 |
24-04-19 | 1,026 | -1.48% | 762,705 |
24-04-18 | 1,042 | -1.72% | 1,139,829 |
24-04-16 | 1,060 | +1.53% | 425,482 |
Delayed Quote NSE India S.E., April 23, 2024 at 07:51 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.14% | 3.52B | |
+17.88% | 44.31B | |
+20.29% | 22.17B | |
+13.05% | 14.62B | |
+8.06% | 13.12B | |
+39.21% | 11.58B | |
-8.72% | 6.96B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+5.03% | 5.03B |
- Stock Market
- Equities
- GLENMARK Stock